I-Mab to Participate in Leerink Partners Global Healthcare Conference

Rhea-AI Summary

I-Mab (NASDAQ: IMAB), a US-based global biotech company focused on precision immune-oncology agents for cancer treatment, has announced its participation in the Leerink Partners Global Healthcare Conference. The conference will take place in Miami, Florida on March 11-12, 2025, where I-Mab's management team will engage in one-on-one meetings with conference attendees.

News Market Reaction – IMAB

+1.56%

+1.56% Session move

In the trading session that priced this news, IMAB gained 1.56%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKVILLE, Md., Feb. 18, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a US-based, global biotech company, exclusively focused on the development of precision immune-oncology agents for the treatment of cancer, today announced that members of I-Mab’s management will participate in one-on-one meetings at the Leerink Partners Global Healthcare Conference in Miami, Florida on Tuesday and Wednesday, March 11-12, 2025.

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.

I-Mab Investor & Media Contacts
PJ Kelleher
LifeSci Advisors
+1-617-430-7579
pkelleher@lifesciadvisors.com
IR@imabbio.com

FAQ

When is I-Mab (IMAB) participating in the Leerink Partners Global Healthcare Conference 2025?

I-Mab will participate in the Leerink Partners Global Healthcare Conference on March 11-12, 2025, in Miami, Florida.

What type of meetings will IMAB management conduct at the Leerink Partners Conference 2025?

I-Mab's management will conduct one-on-one meetings at the conference.

Where is the 2025 Leerink Partners Global Healthcare Conference being held for IMAB?

The conference is being held in Miami, Florida.

What is I-Mab's (IMAB) current business focus according to their latest conference participation?

I-Mab is a US-based, global biotech company exclusively focused on developing precision immune-oncology agents for cancer treatment.